-transparent.png){kind=logo}
In this randomized, double-blind study, 57 patients with ankylosing spondylitis were evaluated after 26 weeks of treatment with either flurbiprofen (Ansaid, Upjohn) or indomethacin. Flurbiprofen administered four times a day in a total daily dose of 200 mg was effective in controlling the pain and associated symptoms of ankylosing spondylitis. Pain was adequately controlled in some patients following a total daily dose of 100 mg of flurbiprofen administered twice a day. Flurbiprofen was as effective as indomethacin in most key efficacy measurements analyzed. The drug was well tolerated in doses of up to 300 mg per day, and no clinically significant laboratory abnormalities were detected. Flurbiprofen is an excellent treatment for the control of pain and inflammation in patients with ankylosing spondylitis.
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
January 1977,
Current medical research and opinion,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
August 1977,
Southern medical journal,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
October 1980,
The New Zealand medical journal,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
March 1974,
Annals of the rheumatic diseases,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
April 1977,
European journal of clinical pharmacology,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
January 1984,
Pharmatherapeutica,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
February 1968,
Arthritis and rheumatism,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
January 1965,
Acta rheumatologica Scandinavica,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
February 1987,
The Journal of rheumatology,
P L Lomen, and
L F Turner, and
K R Lamborn, and
E L Brinn
January 1981,
The British journal of clinical practice,
